2 months ago
CATX
AnalystsYuan ZhiYuan Zhi's Stock Forecasts
AnalystsYuan Zhi
Analyst Ranking
Top 7%
#313 out of 4595 analysts
Average Return
+70.66%
Win Rate
58%11 out of 19
Risk vs Reward
Poor
Good
Yuan Zhi's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Fusion Pharmaceuticals IncFUSN | +554.97% | $3.22 | $21.09 | 2023-10-03 - 2024-03-20 | Strong Buy |
Fusion Pharmaceuticals IncFUSN | +446.37% | $3.86 | $21.09 | 2023-03-30 - 2024-03-20 | Strong Buy |
Fusion Pharmaceuticals IncFUSN | +141.92% | $2.29 | $5.54 | 2022-12-01 - 2023-11-30 | Strong Buy |
Perspective Therapeutics IncCATX | +120.80% | $0.63 | $1.38 | 2024-01-26 - 2024-05-31 | Strong Buy |
Ambrx Biopharma IncAMAM | +89.22% | $14.56 | $27.55 | 2023-06-14 - 2024-01-09 | Strong Buy |
Yuan Zhi Analyst Color
Get additional color on Yuan Zhi's coverage of popular stocks
4 months ago
AZTA
Yuan Zhi's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Cytosorbents CorpCTSO | 1 | Strong Buy | $3.00 | +233.33% | Reiterates | 19 days ago |
Cryoport IncCYRX | 3 | Hold | $19.00 | +84.82% | Downgrades | a month ago |
Perspective Therapeutics IncCATX | 2 | Strong Buy | $1.70 | +23.19% | Maintains | 2 months ago |
Fusion Pharmaceuticals IncFUSN | 4 | Hold | $23.00 | +6.88% | Downgrades | 2 months ago |
Agenus IncAGEN | 1 | Strong Buy | $100.00 | +537.35% | Maintains | 3 months ago |
Azenta IncAZTA | 3 | Strong Buy | $79.00 | +56.40% | Maintains | 4 months ago |
Ambrx Biopharma IncAMAM | 2 | Hold | $28.00 | 0.00% | Downgrades | 5 months ago |
Actinium Pharmaceuticals IncATNM | 4 | Strong Buy | $16.00 | +96.32% | Maintains | 6 months ago |
Tango Therapeutics IncTNGX | 1 | Strong Buy | $16.00 | +131.21% | Initiates Coverage On | 6 months ago |
Iveric Bio IncISEE | 3 | Hold | $19.00 | N/A | Maintains | a year ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.